An Entirely New Generation of Stem Cell Medicines
Creating New Heart Muscle and
New Skeletal Muscle
An Entirely New Generation of Stem Cell Medicines
Creating New Heart Muscle and
New Skeletal Muscle
Daring to ask “What If?”
What if, instead of merely treating disease symptoms, doctors could restore function and health by replacing tissue cells lost or damaged with disease? What if it were possible to trade daily lifelong pharmaceutical regimens for a single treatment that prevents symptoms or starts to cure the underlying disease?
Driven by the opportunity to transform the way we treat disease, IPS HEART is turning “what if” into “here’s how" in two difficult diseases which currently have no approved therapies to reverse the disease. IPS HEART is ushering in a new era of cellular medicines with a transformative impact that can create new heart muscle and new skeletal muscle.
Who are we?
We are committed to transforming the lives of patients suffering devastating disease. From heart attack/heart failure to Duchenne Muscular Dystrophy, we tackle the most challenging conditions head vs. current therapeutics that can only provide symptomatic relief or at best slow the rate of decline in these devastating diseases.
Approach
We believe transformative care that will extend life as well as taking DMD patients out of their wheel chairs should be the goal, not just myopically restoring a missing gene that cannot create new muscle. Similarly for heart attack patients, we believe generating new heart muscle that repairs the #1 source of morbidity worldwide should be the goal.
Pipeline
We are advancing a pipeline of two single-course stem cell therapeutics intended to safely and durably create new heart muscle and new skeletal muscle in cardiac & DMD patients.
Platform
Our proprietary platform uses recently discovered induced pluripotent stem cells (iPSCs) which can create an unlimited number of new cells to repair irreversibly damaged muscle/tissue.